INVITROGEN CORP
8-K, EX-15.2, 2000-09-29
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: INVITROGEN CORP, 8-K, EX-15.1, 2000-09-29
Next: INVITROGEN CORP, 8-K, EX-23.1, 2000-09-29




<PAGE>
                                                                  Exhibit 15.2


Securitites and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549

Commissioners:

We are aware that our report dated July 12, 2000 on our reveiw of the interim
financial information of Life Technologies, Inc. as of June 30, 2000 and for
the three-month and six-month periods ended June 30, 2000 and 1999 and
included in the Company's quarterly report on Form 10-Q for the quarter ended
June 30, 2000 is incorporated by reference in Invitrogen Corporation's
Registration Statements on Form S-8 (Nos. 333-46146, 333-86531, and
333-74061) and is incorporated by reference in this Current Report on Form
8-K of Invitrogen Corporation.

Very truly yours,


/s/ PricewaterhouseCoopers LLP

McLean, Virginia
September 27, 2000





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission